Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-04T02:50:45.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Schizo-obsessive spectrum disorders: an update

Published online by Cambridge University Press:  27 September 2016

Estêvão Scotti-Muzzi  and
Osvaldo Luis Saide
Estêvão Scotti-Muzzi*
Affiliation:
Psychiatry Unit, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, Brazil
Osvaldo Luis Saide
Affiliation:
Psychiatry Unit, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, Brazil
*
*Address for correspondence: Estêvão Scotti-Muzzi, MD, Psychiatry Unit, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Boulevard 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-900, Brazil. (Email: estevaoscotti@gmail.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

The presence of obsessive-compulsive symptoms (OCS) and obsessive-compulsive disorders (OCD) in schizophrenia is frequent, and a new clinical entity has been proposed for those who show the dual diagnosis: the schizo-obsessive disorder. This review scrutinizes the literature across the main academic databases, and provides an update on different aspects of schizo-obsessive spectrum disorders, which include schizophrenia, schizotypal personality disorder (SPD) with OCD, OCD with poor insight, schizophrenia with OCS, and schizophrenia with OCD (schizo-obsessive disorder). An epidemiological discussion on the discrepancies observed in the prevalence of OCS and OCD in schizophrenia across time is provided, followed by an overview of the main clinical and phenomenological features of the disorder in comparison to the primary conditions under a spectral perspective. An updated and comparative analysis of the main genetic, neurobiological, neurocognitive, and pharmacological treatment aspects for the schizo-obsessive spectrum is provided, and a discussion on endophenotypic markers is introduced in order to better understand its substrate. There is sufficient evidence in the literature to demonstrate the clinical relevance of the schizo-obsessive spectrum, although little is known about the neurobiology, genetics, and neurocognitive aspects of these groups. The pharmacological treatment of these patients is still challenging, and efforts to search for possible specific endophenotypic markers would open new avenues in the knowledge of schizo-obsessive spectrum.

Keywords

co-morbidityendophenotypic markerinsightneurocognitionobsessive-compulsive disorderschizophrenia
Type
Review Articles
Information
CNS Spectrums , Volume 22 , Issue 3 , June 2017 , pp. 258 - 272
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

We are deeply indebted to the staff and colleagues from the Psychiatric Unit of the State University of Rio de Janeiro, in particular to Prof. Max de Carvalho for his helpful comments on the dissertation written by ESM and supervised by OLS.

References

1. Jablensky, A. Schizophrenia: the epiemiological horizon. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Vol. 1. Oxford, UK: Blackwell; 1995: 206–252.Google Scholar
2. Bloch, MH, Landeros-Weisenberger, A, Kelmendi, B, Coric, V, Bracken, MB, Leckman, JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006; 11(7): 622–632.CrossRefGoogle ScholarPubMed
3. Berrios, GE. Obsessive–compulsive disorder: its conceptual history in France during the 19th century. Compr Psychiatry. 1989; 30(4): 283–295.Google Scholar
4. Fenton, WS, McGlashan, TH. The prognostic significance of obsessive–compulsive symptoms in schizophrenia. Am J Psychiatry. 1986; 143(4): 437–441.Google ScholarPubMed
5. Schirmbeck, F, Zink, M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol. 2013; 4: 99.CrossRefGoogle ScholarPubMed
6. Hwang, MY, Opler, LA. Schizophrenia with obsessive-compulsive features: assessment and treatment. Psychiatric Annals. 1994; 24(9): 468–472.Google Scholar
7. Hwang, MY, Morgan, JE, Losconzcy, MF. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci. 2000; 12(1): 91–94.CrossRefGoogle ScholarPubMed
8. Bottas, A, Cooke, RG, Richter, MA. Comorbidity and pathophysiology of obsessive–compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci. 2005; 30(3): 187–193.Google Scholar
9. Reznik, I, Kotler, M, Weizman, A. Obsessive and compulsive symptoms in schizophrenia patients—from neuropsychology to clinical typology and classification. J Neuropsychiatry Clin Neurosci. 2005; 17(2): 254–255.CrossRefGoogle ScholarPubMed
10. Poyurovsky, M, Koran, LM. Obsessive–compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. J Psychiatr Res. 2005; 39(4): 399–408.Google Scholar
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
12. Phillips, KA, Stein, DJ, Rauch, S, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety. 2010; 27(6): 528–555.Google Scholar
13. Tumkaya, S, Karadag, F, Oguzhanoglu, NK, O et al. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison. Psychiatry Res. 2009; 165(1–2): 38–46.Google Scholar
14. Catapano, F, Perris, F, Fabrazzo, M, et al. Obsessive-compulsive disorder with poor insight: a three-year prospective study. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34(2): 323–330.CrossRefGoogle ScholarPubMed
15. Poyurovsky, M, Zohar, J, Glick, I, et al. Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Compr Psychiatry. 2012; 53(5): 480–483.CrossRefGoogle ScholarPubMed
16. Murphy, DL, Timpano, KR, Wheaton, MG, Greenberg, BD, Miguel, EC. Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci. 2010; 12(1): 131–148.CrossRefGoogle ScholarPubMed
17. de Haan, L, Dudek-Hodge, C, Verhoeven, Y, Denys, D. Prevalence of psychotic disorders in patients with obsessive-compulsive disorder. CNS Spectr. 2009; 14(8): 415–417.Google Scholar
18. Jacob, ML, Larson, MJ, Storch, EA. Insight in adults with obsessive–compulsive disorder. Compr Psychiatry. 2014; 55(4): 896–903.CrossRefGoogle ScholarPubMed
19. Meier, SM, Petersen, L, Pedersen, MG, et al. Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatry. 2014; 71(11): 1215–1221.Google Scholar
20. Fontenelle, LF, Lin, A, Pantelis, C, Wood, SJ, Nelson, B, Yung, AR. A longitudinal study of obsessive-compulsive disorder in individuals at ultra-high risk for psychosis. J Psychiatr Res. 2011; 45(9): 1140–1145.Google Scholar
21. Fontenelle, LF, Lin, A, Pantelis, C, Wood, SJ, Nelson, B, Yung, AR. Markers of vulnerability to obsessive-compulsive disorder in an ultra-high risk sample of patients who developed psychosis. Early Interv Psychiatry. 2012; 6(2): 201–206.Google Scholar
22. Zink, M, Schirmbeck, MF, Rausch, F, et al. Obsessive–compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function. Acta Psychiatr Scand. 2014; 130(3): 214–216.CrossRefGoogle ScholarPubMed
23. Achim, AM, Maziade, M, Raymond, E, Olivier, D, Mérette, C, Roy, MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011; 37(4): 811–821.Google Scholar
24. Buckley, PF, Miller, BJ, Lehrer, DS, Castle, DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009; 35(2): 383–402.CrossRefGoogle ScholarPubMed
25. Rosen, I. The clinical significance of obsessions in schizophrenia. Br J Psychiatry. 1957; 103(433): 778–785.Google ScholarPubMed
26. Berman, I, Kalinowski, A, Berman, SM, Lengua, J, Green, AI. Obsessive and compulsive symptoms in schizophrenia. Compr Psychiatry. 1995; 36(1): 6–10.Google Scholar
27. Lysaker, PH, Marks, KA, Picone, JB, Rollins, AL, Fastenau, PS, Bond, GR. Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis. 2000; 188(2): 78–83.Google Scholar
28. Oulis, P, Konstantakopoulos, G, Lykouras, L, Michalopoulou, PG. Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: a phenomenological approach. World J Psychiatry. 2013; 3(3): 50–56.CrossRefGoogle ScholarPubMed
29. Matsunaga, H, Kiriike, N, Matsui, T, et al. Obsessive-compulsive disorder with poor insight. Compr Psychiatry. 2002; 43(2): 150–157.Google Scholar
30. Frías, A, Palma, C, Farriol, N, Salvador, A, Bonet, J, Bernáldez, I. Psychopathology and quality of life among patients with comorbidity between schizophrenia spectrum disorder and obsessive-compulsive disorder: no evidence for a “schizo-obsessive” subtype. Compr Psychiatry. 2014; 55(5): 1165–1173.Google Scholar
31. Poyurovsky, M, Faragian, S, Pashinian, A, et al. Clinical characteristics of schizotypal-related obsessive-compulsive disorder. Psychiatry Res. 2008; 159(1–2): 254–258.CrossRefGoogle ScholarPubMed
32. Brakoulias, V, Starcevic, V, Berle, D, et al. The clinical characteristics of obsessive compulsive disorders associated with high levels of schizotypy. Aust N Z J Psychiatry. 2014; 48(9): 852–860.Google Scholar
33. Solem, S, Hagen, K, Wenaas, C, et al. Psychotic and schizotypal symptoms in nonpsychotic patients with obsessive-compulsive disorder. BMC Psychiatry. 2015; 15: 121.CrossRefGoogle ScholarPubMed
34. Melca, IA, Yücel, M, Mendlowicz, MV, de Oliveira-Souza, R, Fontenelle, LF. The correlates of obsessive–compulsive, schizotypal, and borderlinepersonality disorders in obsessive–compulsive disorder. J Anxiety Disord. 2015; 33: 15–24.Google Scholar
35. Frost, RO, Steketee, G, Williams, LF, Warren, R. Mood, personality disorder symptoms and disability in obsessive compulsive hoarders: a comparison with clinical and nonclinical controls. BehavRes Ther. 2000; 38(11): 1071–1081.Google Scholar
36. Rasmussen, J, Steketee, G, Silverman, M, Wilhelm, S. The relationship of hoarding symptoms to schizotypal personality and cognitive schemas in an OCD sample. J Cogn Psychother. 2013; 27(4): 384–396.Google Scholar
37. Kashyap, H, Kumar, JK, Kandavel, T, Reddy, YCJ. Neuropsychological correlates of insight in obessive compulsive disorder. Acta Psychiatr Scand. 2012; 126(2): 106–114.CrossRefGoogle Scholar
38. Kashyap, H, Kumar, JK, Kandavel, T, Reddy, YCJ. The dysfunctional inner mirror: poor insight in obsessive compulsive disorder, contributions to heterogeneity and outcome. CNS Spectr. 2015; 20(5): 460–462.CrossRefGoogle ScholarPubMed
39. Catapano, F, Sperandeo, R, Perris, F, Lanzro, M, Maj, M. Insight and resistance in patients with obsessive-compulsive disorder. Psychopathology. 2001; 34(2): 62–68.CrossRefGoogle ScholarPubMed
40. Zohar, J. Is there room for a new diagnostic subtype—the schizo-obsessive subtype? CNS Spectr. 1997; 2(3): 49–50.Google Scholar
41. Kayahan, B, Ozturk, O, Veznedaroglu, B, Eraslan, D. Obsessive-compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci. 2005; 59(3): 291–295.Google Scholar
42. Öngür, D, Goff, DC. Obsessive–compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res. 2005; 75(2–3): 349–362.Google Scholar
43. Poyurovsky, M, Kriss, V, Weisman, G, et al. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry. 2003; 64(11): 1300–1307.Google Scholar
44. Tiryaki, A, Özkorumak, E. Do the obsessive-compulsive symptoms have an effect in schizophrenia? Compr Psychiatry. 2010; 51(4): 357–362.Google Scholar
45. Lysaker, PH, Bryson, GJ, Marks, KA, Greig, TC, Bell, MD. Association of obsessions and compulsions in schizophrenia with neurocognition and negative symptoms. J Neuropsychiatry Clin Neurosci. 2002; 14(4): 449–453.Google Scholar
46. Tibbo, P, Kroetsch, M, Chue, P, Warneke, L. Obsessive compulsive disorder in schizophrenia. J Psychiatr Res. 2000; 34(2): 139–146.Google Scholar
47. Lysaker, PH, Whitney, KA. Obsessive-compulsive symptoms in schizophrenia: prevalence, correlates and treatment. Expert Rev Neurother. 2009; 9(1): 99–107.Google Scholar
48. Niendam, TA, Berzak, J, Cannon, TD, Bearden, CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009; 108(1–3): 170–175.Google Scholar
49. Faragian, S, Pashinian, A, Fuchs, C, Poyurovsky, M. Obsessive–compulsive symptom dimensions in schizophrenia patients with comorbid obsessive–compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(6): 1009–1012.Google Scholar
50. Faragian, S, Fuchs, C, Pashinian, A, Weizman, R, Weizman, A, Poyurovsky, M. Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder. Psychiatry Res. 2012; 197(1–2): 19–22.Google Scholar
51. Rajkumar, RP, Reddy, YC, Kandavel, T. Clinical profile of “schizo-obsessive” disorder: a comparative study. Compr Psychiatry. 2008; 49(3): 262–268.Google Scholar
52. Poyurovsky, M, Hramenkov, S, Isakov, V, et al. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res. 2001; 102(1): 49–57.Google Scholar
53. Poyurovsky, M, Kriss, V, Weisman, G, et al. Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders in schizophrenia probands with and without OCD. Am J Med Genet B Neuropsychiatr Genet. 2005; 133B(1): 31–66.Google Scholar
54. Hur, JW, Shin, NY, Jang, JH, et al. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms. Aust N Z J Psychiatry. 2012; 46(2): 161–169.CrossRefGoogle ScholarPubMed
55. de Haan, L, Sterk, B, van der Valk, R. Presence of obsessive compulsive symptoms in first-episode schizophrenia or related disorders is associated with subjective well-being and quality of life. Early Interv Psychiatry. 2013; 7(3): 285–290.Google Scholar
56. De Vylder, JE, Oh, AJ, Ben-David, S, Azimov, N, Harkavy-Friedman, JM, Corcoran, CM. Obsessive compulsive symptoms in individuals at clinical risk for psychosis: association with depressive symptoms and suicidal ideation. Schizophr Res. 2012; 140(1–3): 110–113.Google Scholar
57. Weinberger, DR. From neuropathology to neurodevelopment. Lancet. 1995; 346(8974): 552–557.CrossRefGoogle ScholarPubMed
58. Cummings, JL. Frontal–subcortical circuits and human behaviour. Arch Neurol. 1993; 50(8): 873–880.Google Scholar
59. Weinberger, DR, Egan, MF, Bertolino, A, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 2001; 50(11): 825–844.Google Scholar
60. Saxena, S, Brody, AL, Schwartz, JM, Baxter, R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35): 26–37.Google Scholar
61. Cavallaro, R, Cavedini, P, Mistretta, P, et al. Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry. 2003; 54(4): 437–443.Google Scholar
62. Li, X, Branch, CA, Nierenberg, J. Disturbed functional connectivity of cortical activation during semantic discrimination in patients with schizophrenia and subjects at genetic high-risk. Brain Imaging Behav. 2010; 4(1): 109–120.Google Scholar
63. Bleich-Cohen, M, Sharon, H, Weizman, R, Poyurovsky, M, Faragian, S, Hendler, T. Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivity. Schizophr Res. 2012; 134(2–3): 131–136.Google Scholar
64. Aoyama, F, Iida, J, Inoue, M, et al. Brain imaging in childhood- and adolescence-onset schizophrenia associated with obsessive-compulsive symptoms. Acta Psychiatr Scand. 2000; 102(1): 32–37.CrossRefGoogle ScholarPubMed
65. Kwon, JS, Shin, YW, Kim, CW, et al. Similarity and disparity of obsessive compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry. 2003; 74(7): 962–964.Google Scholar
66. Kim, JJ, Youn, T, Lee, JM, Kim, IY, Kim, SI, Kwon, JS. Morphometric abnormality of the insula in schizophrenia: a comparison with obsessive–compulsive disorder and normal control using MRI. Schizophr Res. 2003; 60(2–3): 191–198.Google Scholar
67. Ha, TH, Yoon, U, Lee, KJ, et al. Fractal dimension of cerebral cortical surface in schizophrenia and obsessive–compulsive disorder. Neurosci Lett. 2005; 384(1–2): 172–176.Google Scholar
68. Benkelfat, C, Murphy, DL, Zohar, J, Hill, JL, Grover, G, Insel, TR. Clomipramine in obsessive-compulsive disorder: further evidence for a serotonergic mechanism of action. Arch Gen Psychiatry. 1989; 46(1): 23–28.Google Scholar
69. Zohar, J, Insel, TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry. 1987; 22(6): 667–687.CrossRefGoogle ScholarPubMed
70. Ma, N, Tan, LW, Wang, Q, Li, ZX, Li, LJ. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Psychiatry Res. 2007; 150(1): 61–69.Google Scholar
71. Asami, T, Whitford, TJ, Bouix, S, et al. Globally and locally reduced MRI gray matter volumes in neuroleptic-naive men with schizotypal personality disorder: association with negative symptoms. JAMA Psychiatry. 2013; 70(4): 361–372.CrossRefGoogle ScholarPubMed
72. Harris, CL, Dinn, WM. Subtyping obsessive-compulsive disorder: neuropsychological correlates. Behav Neurol. 2003; 14(3–4): 75–87.Google Scholar
73. Shin, NY, Lee, AR, Park, HY, et al. Impact of coexistent schizotypal personality traits on frontal lobe function in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32(2): 472–478.CrossRefGoogle ScholarPubMed
74. Huang, LC, Hwang, TJ, Huang, GH, Hwu, HG. Outcome of severe obsessive-compulsive disorder with schizotypal features: a pilot study. J Formos Med Assoc. 2011; 110(2): 85–92.CrossRefGoogle ScholarPubMed
75. Aigner, M, Zitterl, W, Prayer, D, et al. Magnetic resonance imaging in patients with obsessive-compulsive disorder with good versus poor insight. Psychiatry Res. 2005; 140(2): 173–179.Google Scholar
76. Levine, JB, Gruber, SA, Baird, AA, Yurgelun-Todd, D. Obsessive–compulsive disorder among schizophrenic patients: an exploratory study using functional magnetic resonance imaging data. Compr Psychiatry. 1998; 39(5): 308–311.Google Scholar
77. Bleich-Cohen, M, Hendler, T, Weizman, R, Faragian, S. Working memory dysfunction in schizophrenia patients with obsessive- compulsive symptoms: an fMRI study. Eur Psychiatry. 2014; 29(3): 160–166.CrossRefGoogle ScholarPubMed
78. Barch, DM, Ceaser, A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci. 2012; 16(1): 27–34.Google Scholar
79. Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005; 29(3): 399–419.Google Scholar
80. Bleich-Cohen, M, Jamshy, S, Sharon, H, et al. Machine learning fMRI classifier delineates subgroups of schizophrenia patients. Schizophr Res. 2014; 160(1–3): 196–200.CrossRefGoogle ScholarPubMed
81. Bleich-Cohen, M, Poyurovsky, M, Hendler, T, Weizman, R, Sharon, H. Does co-morbid obsessive–compulsive disorder modify the abnormal language processing in schizophrenia patients? An fMRI study. Front Hum Neurosci. 2014; 8: 560.CrossRefGoogle ScholarPubMed
82. Hashim, HM, Fawzy, N, Fawzi, MM, Karam, RA. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients. J Psychiatr Res. 2012; 46(6): 762–766.Google Scholar
83. Kwon, JS, Joo, YH, Nam, HJ, et al. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry. 2009; 66(11): 1233–1241.Google Scholar
84. Arnold, PD, Sicard, T, Burroughs, E, Richter, MA, Kennedy, JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006; 63(7): 769–776.Google Scholar
85. Deng, X, Shibata, H, Takeuchi, N, et al. Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B(3): 271–278.Google Scholar
86. Cai, J, Zhang, W, Lu, W, et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology (Berl). 2013; 230(1): 49–55.Google Scholar
87. Pantelis, C, Maruff, P. The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. J. Psychosom Res. 2002; 53(2): 655–664.CrossRefGoogle ScholarPubMed
88. Pallanti, S, Castellini, G, Chamberlain, S, Quercioli, L, Zaccara, C, Fineberg, NA. Cognitive event-related potentials differentiate schizophrenia with obsessive compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms. Psychiatry Res. 2009; 170(1): 52–60.Google Scholar
89. Donchin, E, Coles, MHG. Is the P300 component a manifestation of context updating? Behav Brain Sci. 1988; 11(3): 357–374.Google Scholar
90. Roth, WT, Cannon, EH. Some features of the auditory evoked response in schizophrenics. Arch Gen Psychiatry. 1972; 27(4): 466–471.CrossRefGoogle ScholarPubMed
91. Romani, A, Merello, S, Gozzoli, L, Zerbi, F, Grassi, M, Cosi, V. P300 and CT scan in patients with chronic schizophrenia. Br J Psychiatry. 1987; 151(4): 506–513.Google Scholar
92. McCarley, RW, Shenton, ME, O’Donnell, BF, et al. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry. 1993; 50(3): 190–197.Google Scholar
93. Frangou, S, Sharma, T, Alarcon, G, Sigmudsson, T, Takei, N, Binnie, C. The Maudsley Family Study, II. Endogenous event-related potentials in familial schizophrenia. Schizophr Res. 1997; 23(1): 45–53.Google Scholar
94. Bahramali, H, Gordon, E, Li, WM, Rennie, C, Wright, J, Meares, R. Fast and slow reaction times and associated ERPs in patients with schizophrenia and controls. Int J Neurosci. 1998; 95(3–4): 155–165.Google Scholar
95. Frodl-Bauch, T, Gallinat, J, Meisenzahl, EM, Möller, HJ, Hegerl, U. P300 subcomponents reflect different aspects of psychopathology in schizophrenia. Biol Psychiatry. 1999; 45(1): 116–126.Google Scholar
96. Mathalon, DH, Ford, JM, Rosenbloom, M, Pfefferbaum, A. P300 reduction and prolongation with illness duration in schizophrenia. Biol Psychiatry. 2000; 47(5): 413–427.CrossRefGoogle ScholarPubMed
97. Martin-Loeches, M, Molina, V, Muñoz, F, et al. P300 amplitude as a possible correlate of frontal degeneration in schizophrenia. Schizophr Res. 2001; 49(1–2): 121–128.CrossRefGoogle ScholarPubMed
98. Bramon, E, Rabe-Hesketh, S, Sham, P, Murray, R, Frangou, S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res. 2004; 70(2–3): 315–329.CrossRefGoogle ScholarPubMed
99. Abramovitch, A, Abramowitz, JS, Mittelman, A. The neuropsychology of adult obsessive–compulsive disorder: a meta-analysis. Clin Psychol Rev. 2013; 33(8): 1163–1171.Google Scholar
100. Rosell, DR, Futterman, SE, McMaster, A, Siever, LJ. Schizotypal personality disorder: a current review. Curr Psychiatry Rep. 2014; 16(7): 452.Google Scholar
101. Mitropoulou, V, Harvey, PD, Maldari, LA, et al. Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry. 2002; 52(12): 1175–1182.Google Scholar
102. Kitis, A, Akdede, BBK, Alptekin, K, et al. Cognitive dysfunctions in patients with obsessive–compulsive disorder compared to the patients with schizophrenia: relation to overvalued ideas. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(1): 254–261.Google Scholar
103. Meijer, JH, Swets, M, Keeman, S, Nieman, DH, Meijer, CJ, GROUP Investigators. Is a schizo-obsessive subtype associated with cognitive impairment? Results from a large cross-sectional study in patients with psychosis and their unaffected relatives. J Nerv Ment Dis. 2013; 201(1): 30–35.CrossRefGoogle ScholarPubMed
104. Borkowska, A, Pilaczyñska, E, Rybakowski, JK. The frontal lobe neuropsychological tests in patients with schizophrenia and/or obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 2003; 15(3): 359–362.Google Scholar
105. Lee, MJ, Shin, YB, Sunwoo, YK, et al. Comparative analysis of cognitive function in schizophrenia with and without obsessive compulsive disorder. Psychiatry Investig. 2009; 6(4): 286–293.Google Scholar
106. Berman, I, Merson, A, Viegner, B, Losonczy, MF, Pappas, D, Green, AI. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998; 186(3): 150–156.Google Scholar
107. Lysaker, PH, Whitney, KA, Davis, LW. Associations of executive function with concurrent and prospective reports of obsessive–compulsive symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci. 2009; 21(1): 38–42.Google Scholar
108. Patel, DD, Laws, KR, Padhi, A, et al. The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis. Psychol Med. 2010; 40(6): 921–933.Google Scholar
109. Schirmbeck, F, Rausch, F, Englisch, S, et al. Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study. Schizophrenia Bull. 2013; 39(6): 1261–1271.Google Scholar
110. Kumbhani, SR, Roth, RM, Kruck, CL, Flashman, LA, McAllister, TW. Nonclinical obsessive-compulsive symptoms and executive functions in schizophrenia. J Neuropsychiatry Clin Neurosci. 2010; 22(3): 304–312.CrossRefGoogle ScholarPubMed
111. Michalopoulou, PG, Konstantakopoulos, G, Typaldou, M, et al. Can cognitive deficits differentiate between schizophrenia with and without obsessive–compulsive symptoms? Compr Psychiatry. 2014; 55(4): 1015–1021.CrossRefGoogle ScholarPubMed
112. Ntouros, E, Bozikas, VP, Andreou, C, Kourbetis, D, Lavrentiadis, G, Garyfallos, G. Emotional perception and theory of mind in first episode psychosis: the role of obsessive–compulsive symptomatology. Psychiatry Res. 2014; 220(1–2): 112–117.Google Scholar
113. Hermesh, H, Weizman, A, Gur, S, et al. Alternation learning in OCD/schizophrenia patients. Eur Neuropsychopharmacol. 2003; 13(2): 87–91.Google Scholar
114. Kim, M, Kang, S, Youn, T, Kang, D, Kim, J, Kwon, JS. Neuropsychological correlates of P300 abnormalities in patients with schizophrenia and obsessive–compulsive disorder. Psychiatry Res. 2003; 123(2): 109–123.Google Scholar
115. Frangou, S. Snipping at the endophenotypic space. Am J Psychiatry. 2013; 170(11): 1223–1225.CrossRefGoogle ScholarPubMed
116. Gottesman, II, Gould, TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160(4): 636–645.Google Scholar
117. Docherty, AR, Coleman, MJ, Tu, X, Deutsch, CK, Mendell, NR, Levy, DL. Comparison of putative intermediate phenotypes in schizophrenia patients with and without obsessive-compulsive disorder: examining evidence for the schizo-obsessive subtype. Schizophr Res. 2012; 140(1–3): 83–86.Google Scholar
118. Allen, AJ, Griss, ME, Folley, BS, Hawkins, KA, Pearlson, GD. Endophenotypes in schizophrenia: a selective review. Schizophr Res. 2009; 109(1–3): 24–37.Google Scholar
119. Menzies, L, Achard, S, Chamberlain, SR, et al. Neurocognitive endophenotypes of obsessive–compulsive disorder. Brain. 2007; 130(Pt 12): 3223–3236.Google Scholar
120. Chamberlain, SR, Fineberg, NA, Blackwell, AD, Robbins, TW, Sahakian, BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry. 2006; 163(7): 1282–1284.Google Scholar
121. Chamberlain, SR, Fineberg, NA, Menzies, LA, et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007; 164(2): 335–338.Google Scholar
122. Rajender, G, Bhatia, MS, Kanwal, K, Malhotra, S, Singh, TB, Chaudhary, D. Study of neurocognitive endophenotypes in drug-naïve obsessive-compulsive disorder patients, their first-degree relatives and healthy controls. Acta Psychiatr Scand. 2011; 124(2): 152–161.Google Scholar
123. Morein-Zamir, S, Fineberg, NA, Robbins, TW, Sahakian, BJ. Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype? Psychol Med. 2010; 40(2): 263–272.Google Scholar
124. Braff, DL, Freedman, R. Endophenotypes in studies of the genetics of schizophrenia. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott, Williams & Wilkins; 2002; 103–116.Google Scholar
125. Saperstein, AM, Fuller, RL, Avila, MT, et al. Spatial working memory as a cognitive endophenotype of schizophrenia: assessing risk for pathophysiological dysfunction. Schizophr Bull. 2006; 32(3): 498–506.Google Scholar
126. Tumkaya, S, Karadag, F, Oguzhanoglu, NK. Neurological soft signs in schizophrenia and obsessive compulsive disorder spectrum. Eur Psychiatry. 2012; 27(3): 192–199.Google Scholar
127. Souza, BR, Torres, KCL, Miranda, DM, et al. Lack of effects of typical and atypical antipsychotics in DARPP-32 and NCS-1 levels in PC12 cells overexpressing NCS-1. J Negat Results Biomed. 2010; 9: 4.Google Scholar
128. Gillman, PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol. 2007; 151(6): 737–748.Google Scholar
129. Feinberg, M. Clomipramine for obsessive-compulsive disorder. Am Fam Physician. 1991; 43(5): 1735–1738.Google Scholar
130. Skapinakis, P, Papatheodorou, T, Mavreas, V. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol. 2007; 17(2): 79–93.Google Scholar
131. Stein, DJ, Koen, N, NA, Fineberg, et al. A 2012 Evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep. 2012; 14(3): 211–219.CrossRefGoogle ScholarPubMed
132. Dold, M, Aigner, M, Lanzenberger, R, Kasper, S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol. 2013; 16(3): 557–574.Google Scholar
133. Jenike, MA, Baer, L, Minichiello, WE, Schwartz, CE, Carey, RJ Jr. Concomitant obsessive–compulsive disorder and schizotypal personality disorder. Am J Psychiatry. 1986; 143(4): 530–532.Google Scholar
134. Dinn, WM, Aycicegi-Dinn, A, Göral, F, Yildirim, EA, Hacioglu, M. Treatment-resistant obsessive-compulsive disorder: clinical and personality correlates. Procedia Soc Behav Sci. 2014; 159: 239–242.Google Scholar
135. Bogetto, F, Bellini, S, Vaschetto, P, Ziero, S. Olanzapine augmentation of fluvoxamine-refractory obsessive–compulsive disorder (OCD): a 12-week open trial. Psychiatry Res. 2000; 96(2): 91–98.Google Scholar
136. Himle, JA, Van Etten, ML, Janeck, AS, Fischer, DJ. Insight as a predictor of treatment outcome in behavioral group treatment for obsessive–compulsive disorder. Cognitive Therapy and Research. 2006; 30(5): 661–666.Google Scholar
137. Ravi Kishore, V, Samar, R, Janardhan Reddy, YC, Chandrasekhar, CR, Thennarasu, K. Clinical characteristics and treatment response in poor and good insight obsessive–compulsive disorder. Eur Psychiatry. 2004; 19(4): 202–208.Google Scholar
138. Shetti, CN, Reddy, YC, Kandavel, T, et al. Clinical predictors of drug nonresponse in obsessive–compulsive disorder. J Clin Psychiatry. 2005; 66(12): 1517–1523.Google Scholar
139. Tolin, DF, Maltby, N, Diefenbach, GJ, Hannan, SE, Worhunsky, P. Cognitive–behavioral therapy for medication nonresponders with obsessive–compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry. 2004; 65(7): 922–931.Google Scholar
140. Demet, MM, Deveci, A, Taşkin, EO, et al. Risk factors for delaying treatment seeking in obsessive–compulsive disorder. Compr Psychiatry. 2010; 51(5): 480–485.Google Scholar
141. Eisen, JL, Rasmussen, SA, Phillips, KA, et al. Insight and treatment outcome in obsessive–compulsive disorder. Compr Psychiatry. 2001; 42(6): 494–497.CrossRefGoogle ScholarPubMed
142. Bandelow, B, Zohar, J, Hollander, E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry. 2008; 9(4): 248–312.Google Scholar
143. Soomro, GM, Altman, D, Rajagopal, S, Oakley-Browne, M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;(1): CD001765.Google Scholar
144. Stryjer, R, Dambinsky, Y, Timinsky, I, Green, T, Kotler, M, Weizman, A, Spivak, B. Escitalopram in the treatment of patients with schizophrenia and obsessive -compulsive disorder: an open-label, prospective study. J Clin Psychopharmacol. 2013; 28(2): 96–98.Google Scholar
145. DeBattista, C, Sofuoglu, M, Schatzberg, AF. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. Biol Psychiatry. 1998; 44(5): 341–347.Google Scholar
146. Schirmbeck, F, Esslinger, C, Rausch, F, Englisch, S, Meyer-Lindenberg, A, Zink, M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011; 41(11): 2361–2373.Google Scholar
147. de Haan, L, Linszen, DH, Gorsira, R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry. 1999; 60(6): 364–365.Google Scholar
148. Lykouras, L, Alevizos, B, Michalopoulou, P, Rabavilas, A. Obsessive–compulsive symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(3): 333–346.Google Scholar
149. de Haan, L, Oekeneva, A, van, A T, Linszen, D. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry. 2004; 19(8): 524.Google Scholar
150. Fonseka, TM, Richter, MA, Müller, DJ. Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Curr Psychiatry Rep. 2014; 16(11): 510.Google Scholar
151. Schirmbeck, F, Zink, M. Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012; 10(1): 88–95.Google Scholar
152. Schirmbeck, F, Mier, D, Esslinger, C, et al. Increased orbitofrontal cortex activation associated with “pro-obsessive” antipsychotic treatment in patients with schizophrenia. J Psychiatry Neurosci. 2015; 40(2): 89–99.Google Scholar
153. Juven-Wetzler, A, Fostick, L, Cwikel-Hamzany, S, Balaban, E, Zohar, J. Treatment with Ziprasidone for schizophrenia patients with OCD. Eur Neuropsychopharmacol. 2014; 24(9): 1454–1462.Google Scholar